These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25045326)

  • 1. Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.
    Wiederkehr MR; Moe OW
    Clin Rev Bone Miner Metab; 2011 Dec; 9(3-4):207-217. PubMed ID: 25045326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
    Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
    Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A; Esposito N; Castelnuovo C
    Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid nephrolithiasis.
    Halabe A; Sperling O
    Miner Electrolyte Metab; 1994; 20(6):424-31. PubMed ID: 7783706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and clinical pathophysiology of uric acid kidney stones.
    Sakhaee K
    J Nephrol; 2014 Jun; 27(3):241-5. PubMed ID: 24497296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Intake and High Uric Acid Stone Risk.
    Montgomery TA; Nair HR; Phadke M; Morhardt E; Ludvigson A; Motamedinia P; Singh D; Dahl NK
    Kidney Med; 2024 Sep; 6(9):100878. PubMed ID: 39279882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid nephrolithiasis.
    Liebman SE; Taylor JG; Bushinsky DA
    Curr Rheumatol Rep; 2007 Jun; 9(3):251-7. PubMed ID: 17531180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K; Maalouf NM
    Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid stones.
    Asplin JR
    Semin Nephrol; 1996 Sep; 16(5):412-24. PubMed ID: 8890397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uric acid nephrolithiasis].
    Dussol B
    Rev Prat; 2011 Mar; 61(3):389-92. PubMed ID: 21563421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid nephrolithiasis.
    Cameron MA; Sakhaee K
    Urol Clin North Am; 2007 Aug; 34(3):335-46. PubMed ID: 17678984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
    Maalouf NM; Poindexter JR; Adams-Huet B; Moe OW; Sakhaee K
    Kidney Int; 2019 May; 95(5):1262-1268. PubMed ID: 30795852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.